NOVARTIS GETS HEALTH CANADA APPROVAL FOR FEMARA TO TREAT BREAST CANCER

Novartis Pharmaceuticals Canada announced the Health Canada approval of Femara, or letrozole, as adjuvant (post-surgery) treatment for postmenopausal women with hormone receptor-positive early breast cancer. Trading Markets (http://www.tradingmarkets.com/.site/news/BREAKING%20NEWS/449422/)